Page 84 - Cardiac Electrophysiology | A Modeling and Imaging Approach
P. 84

P. 84
        Membrane excitability (dV /dt       ) and conduction velocity both decrease, until conduction
                                     m    max
        failure occurs at  [K ] >14.4mM (hyperkalemia alone) or [K ] >13.1mM (with additional presence of
                                                                       +
                             +
                               0                                        0
        acidosis). These values of extracellular potassium concentration are within the range measured
        during acute ischemia.   Importantly, the slowest velocity attainable just before propagation
                                  210
        fails is ~ 17cm/sec (hyperkalemia alone) or 27cm/sec (with acidosis), consistent with experimental
        observations.  202,205  These are relatively fast velocities, consistent with macro-reentry circuits (rather
        than micro-reentry circuits) as the mechanism of arrhythmias during acute ischemia. Clearly,
        this finding is consistent with the principle established in the previous section, that reduced
        membrane excitability cannot support very slow conduction and favors failure of propagation.

        Conduction is I – dependent even at greatly elevated [K ] , with only very minor contribution
                                                                      +
                         Na                                             0
        from I    .
               Ca,L
                                                                           Figure 3.7.  Effects of ischemia on
                                                                           AP propagation. “Comma shaped”
                                                                           relationship between dV /dt    max  and
                                                                                                      m
                                                                           conduction velocity is shown for
                                                                           hyperkalemia alone (non-acidotic,
                                                                           solid trace) and hyperkalemia in
                                                                           presence of acidosis (acidotic, dashed
                                                                           trace). A. Theoretical simulations;
                                                                           numbers indicate [K ] (in mM).
                                                                                                 +
                                                                                                   0
                                                                           Propagation fails at [K ] =14.4mM
                                                                                                   +
                                                                                                    0
                                                                           in the non-acidotic fiber and at
                                                                           [K ] =13.1mM in the acidotic fiber.
                                                                             +
                                                                              0
                                                                           B. Experimental data obtained
                                                                           under similar conditions from guinea
                                                                           pig papillary muscle. From Shaw and
                                                                           Rudy [209], (experimental data from
                                                                           Kagiyama et. al. [205]), with
                                                                           permission from Wolters Kluwer
                                                                           Health, Inc.
   79   80   81   82   83   84   85   86   87   88   89